The US government and Gilead Sciences have announced a landmark plan to supply the long-acting HIV prevention drug, lenacapavir, at cost to high-burden countries. This initiative aims to protect 2 million people via PEPFAR and The Global Fund. In a major step forward...
South Africa will introduce a new lenacapavir injection. This twice-yearly shot is for HIV prevention. It will be in select public clinics by April 2026. This marks a big step forward for the nation. It offers a great alternative to daily pills. However, another...
Citizens are dangerously exposed during emergencies. The National Department of Health reports a major deficit. This is South Africa’s ambulance crisis. It has tragic consequences for patients. The Shocking Scale of South Africa’s Ambulance Crisis The...
Doctors in Bloemfontein have confirmed a new case. It is the first of its kind in the region. This rare fungal infection is very aggressive. Researchers found it in a severely immunocompromised patient. This poses a new and dangerous threat. A team from UFS and NHLS...
South Africa will introduce a groundbreaking twice-yearly HIV prevention injection, lenacapavir, in select public clinics by April 2026. This move marks a significant step forward in the nation’s fight against HIV, offering a highly effective and convenient...
